Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Renaissance sells non-sterile topicals and generics businesses to Mylan for $950mm

Executive Summary

Mylan NV paid $950mm in cash up front to acquire Renaissance Acquisition Holdings LLC's non-sterile, topical specialty and generic dermatology business, which had 2015 revenue of $370mm. Renaissance could get another $50mm in earn-outs.
Deal Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Divestiture/Spin-Out
    • Payment Includes Stock
    • Includes Earnout

Related Companies